WVXU: Meet the UC doctor trying to change minds skeptical of the COVID-19 vaccine
Louito Edje, MD, says the COVID-19 vaccine is based on years of science
Louito Edje, MD, associate dean of graduate medical education at the University of Cincinnati College of Medicine and UC Medical Center, spoke with WVXU about why she is on a public relations blitz – she was featured in segments on CNBC, TMZ, BET and MSNBC - to change minds about vaccinations for COVID-19. The pandemic is having a disproportionate impact on Black Americans and Edje, a Black female physician, is hoping her participation in the Moderna vaccine trial and her voice may sway some opinions about vaccine safety and efficacy.
After her second dose, Edje was pretty sure she didn’t get a placebo as part of the vaccine trial. "I had a lead arm and it lasted about 24 hours and not much longer than that," Edje told WVXU listeners. "I was able to continue working." She feels fine now and says the risk of being in a trial group was worth it to her because she's lost four family members to COVID-19.
Listen to the WVXU interview with Louito Edje, MD, online.
Louito Edje, MD, seated is shown in the UC College of Medicine Simulation Center. Photo by Colleen Kelley/University of Cincinnati.
Impact Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
The Last Show with David Cooper discusses AI in education with UC’s Joshua Lambert
April 12, 2026
The Last Show with David Cooper, a global news podcast, featured Joshua Lambert, PhD, a professor and biostatistician in UC College of Nursing to discuss his latest research on using artificial intelligence for student advising.
UC enrolls first patients in clinical trial for prosthetic joint infections
April 10, 2026
The University of Cincinnati has enrolled the first patients in Peptilogics’ RETAIN clinical trial, testing an investigational drug for prosthetic joint infections after total knee replacement to reduce repeat surgeries and infection recurrence.
Long before machine guns, ancient Romans used this rapid-fire weapon
April 9, 2026
Smithsonian highlights research by UC Classics Professor Steven Ellis, who supervised archaeological work in the Porta Stabia neighborhood of Pompeii.